Back to Search Start Over

Common Variant Near HEY2 Has a Protective Effect on Ventricular Fibrillation Occurrence in Brugada Syndrome by Regulating the Repolarization Current

Authors :
Shunsuke Tomomori
Hiroshi Kawazoe
Takehito Tokuyama
Kazuyoshi Suenari
Nozomu Oda
Akinori Sairaku
Noboru Oda
Satoshi Tashiro
Chikaaki Motoda
Yasufumi Hayashida
Shinji Kishimoto
Hiroya Matsumura
Yukihiko Yoshida
Daiki Miki
Masaaki Toshishige
Yoshikazu Watanabe
Hidenori Ochi
Hiroki Ikenaga
Yuko Onohara
Yukiko Nakano
Kazuaki Chayama
Yasuki Kihara
Source :
Circulation: Arrhythmia and Electrophysiology. 9
Publication Year :
2016
Publisher :
Ovid Technologies (Wolters Kluwer Health), 2016.

Abstract

Background— Risk stratification of Brugada syndrome (BrS) remains controversial and the majority of patients with BrS have no genetic explanation. We investigated relationships between genotypes of 3 single-nucleotide polymorphisms reported in a recent genome-wide association study and BrS phenotypes. Methods and Results— SCN10A (rs10428132), SCN5A (rs11708996), and downstream from HEY2 (rs9388451) single-nucleotide polymorphisms were genotyped and compared between 95 Japanese patients with BrS and 1978 controls. Relationships between the single-nucleotide polymorphisms and clinical characteristics, 12-lead ECG findings, signal-averaged ECG findings, and electrophysiological parameters were also examined in patients with BrS. Both rs10428132 and rs9388451 were significantly associated with BrS ( P =2.7×10 −14 ; odds ratio, 3.0; P =9.2×10 −4 ; odds ratio, 1.7, respectively). Interestingly, the HEY2 risk allele C was less frequent in BrS patients with ventricular fibrillation than in those without (59% versus 74%; P =4.1×10 −2 ; odds ratio, 0.5). A significant linear correlation was found between HEY2 genotypes and QTc interval (CC: 422±27 ms; CT: 408±21 ms; and TT: 381±27 ms; P = 4.0×10 −4 ). The HEY2 mRNA expression level in the right ventricular specimens from patients with BrS (n=20) was significantly lower in patients with CC genotype than the other genotypes ( P =0.04). Additionally, during 63±28 months follow-up periods after implantable cardioverter defibrillator implantation (n=90), Kaplan–Meier event-free survival curves revealed that the cumulative rate of ventricular fibrillation events was significantly lower in cases with HEY2 CC genotype ( P =0.04). Conclusions— Our findings suggest that HEY2 CC genotype may be a favorable prognostic marker for BrS, protectively acting to prevent ventricular fibrillation presumably by regulating the repolarization current.

Details

ISSN :
19413084 and 19413149
Volume :
9
Database :
OpenAIRE
Journal :
Circulation: Arrhythmia and Electrophysiology
Accession number :
edsair.doi.dedup.....1d8d8eb4d8ebe1cf6f061e5a5a4dba03
Full Text :
https://doi.org/10.1161/circep.115.003436